Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 
Supreme Court Signals Skepticism Toward Hawaii Handgun Carry Law 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
The country's top antitrust regulator Korea Fair Trade Commission (KFTC) could probe Samsung Life Insurance for violating shareholder regulations in allegedly providing improper benefits to another affiliate.
It is currently facing punitive measures by financial authorities on the same allegation.
The KFTC said it received filings by a local civic group Solidarity for Economic Reform last week and is considering whether to open a probe into Samsung Life Insurance for allegedly providing improper benefits to another affiliate.
It is alleged that Samsung's life insurance unit exempted the IT service provider Samsung SDS from paying indemnities for failing to complete a 156 billion won project on time.
In a 156.1 billion won contract that Samsung Life signed with Samsung SDS in 2015, the latter is required to set up an enterprise resource planning (ERP) system to manage business processes by April 2017.
The project was not completed until October 2017.
Samsung Life subsequently failed to file 15 billion won in indemnities against Samsung SDS for the delay.
Financial authorities determined that Samsung's life insurance affiliate, which owns stakes in Samsung SDS, decided to sustain losses for the latter’s benefit.
This is seen as a possible violation of regulations that limit transactions by major shareholders.
In December 2020, the FSS decided to sanction Samsung Life for the move, in addition to other issues concerning insurance payments.
